Literature DB >> 16825329

Cross-talk between the kidney and the cardiovascular system.

Kerstin Amann1, Christoph Wanner, Eberhard Ritz.   

Abstract

In recent years, increasing evidence has been provided that even minor renal dysfunction is a powerful cardiovascular risk factor that induces typical cardiovascular alterations and thus predisposes to coronary heart disease as well as to noncoronary cardiovascular problems. This first had been noted in patients with diabetes but now has been confirmed amply in patients without diabetes as well. Numerous heterogeneous abnormalities have been described in patients with early renal dysfunction (e.g., microalbuminuria, reduced estimated GFR). One final common pathway seems to be endothelial cell dysfunction. The link between albuminuria and generalized endothelial cell dysfunction (as indicated by diminished flow-mediated vasodilation, markers of endothelial cell dysfunction, sloughed off endothelial cells, and high transcapillary albumin escape rate) is unclear. In patients with early renal dysfunction, a long list of classical and nonclassical cardiovascular risk factors have been identified: Elevated asymmetric dimethyl-l-arginine concentrations, markers of microinflammation, oxidative stress, features of metabolic syndrome, abnormal adipokine concentrations, dyslipidemia, inappropriate activation of the renin-angiotensin system, and sympathetic overactivity. The mechanisms that link dysfunction of the kidney and the cardiovascular system are being sought. The most interesting unifying concept, however, is deranged fetal programming linking nephron underdosing to the increased cardiovascular risk.

Entities:  

Mesh:

Year:  2006        PMID: 16825329     DOI: 10.1681/ASN.2006030204

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  40 in total

1.  High glucose causes dysfunction of the human glomerular endothelial glycocalyx.

Authors:  A Singh; V Fridén; I Dasgupta; R R Foster; G I Welsh; J E Tooke; B Haraldsson; P W Mathieson; S C Satchell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-27

2.  The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

Authors:  Giovana S Di Marco; Stefan Reuter; Uta Hillebrand; Susanne Amler; Maximilian König; Etienne Larger; Hans Oberleithner; Eva Brand; Hermann Pavenstädt; Marcus Brand
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

3.  Physical activity and change in estimated GFR among persons with CKD.

Authors:  Cassianne Robinson-Cohen; Alyson J Littman; Glen E Duncan; Noel S Weiss; Michael C Sachs; John Ruzinski; John Kundzins; Denise Rock; Ian H de Boer; T Alp Ikizler; Jonathan Himmelfarb; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 4.  Midkine regulation of the renin-angiotensin system.

Authors:  Kenji Kadomatsu
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

5.  Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs.

Authors:  Ronit Lavi; Xiang-Yang Zhu; Alejandro R Chade; Jing Lin; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-04       Impact factor: 8.311

Review 6.  Why do young people with chronic kidney disease die early?

Authors:  Shankar Kumar; Richard Bogle; Debasish Banerjee
Journal:  World J Nephrol       Date:  2014-11-06

7.  The growth factor midkine regulates the renin-angiotensin system in mice.

Authors:  Akinori Hobo; Yukio Yuzawa; Tomoki Kosugi; Noritoshi Kato; Naoto Asai; Waichi Sato; Shoichi Maruyama; Yasuhiko Ito; Hiroyuki Kobori; Shinya Ikematsu; Akira Nishiyama; Seiichi Matsuo; Kenji Kadomatsu
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

Review 8.  Contemporary Management of Coronary Artery Disease and Acute Coronary Syndrome in Patients with Chronic Kidney Disease and End-Stage Renal Disease.

Authors:  Chin-Chou Huang; Jaw-Wen Chen
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

Review 9.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

10.  Adiponectin regulates albuminuria and podocyte function in mice.

Authors:  Kumar Sharma; Satish Ramachandrarao; Gang Qiu; Hitomi Kataoka Usui; Yanqing Zhu; Stephen R Dunn; Raogo Ouedraogo; Kelly Hough; Peter McCue; Lawrence Chan; Bonita Falkner; Barry J Goldstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.